Cell and gene therapy companies develop advanced treatments that modify, replace or engineer cells and genetic material to treat disease. The field is one of the fastest-growing areas of biotechnology and precision medicine.
This category includes companies working on:
Browse 144 UK cell and gene therapy companies below.
NGS-based platform for off-target gene editing detection and characterisation
Broken String Biosciences is a Cambridge-based genomics company developing tools to improve the safety of cell and gene therapies. Its platform uses next-generation sequencing to…
Manufacturing management software for cell and gene therapy production
Autolomous is a software company developing cloud-native manufacturing management systems for cell and gene therapy production. Its platform digitises and integrates the full GMP…
Human iPSC-derived cells and services for drug discovery research
Axol Bioscience is a biotechnology company manufacturing and supplying human induced pluripotent stem cell-derived cells and outsourced laboratory services for drug discovery and…
In vivo lentiviral CAR/TCR cell therapy platform for ovarian cancer
Akimbo Bio is an early-stage biotechnology company developing next-generation in vivo lentiviral vector technology for cell therapy. Its lead platform carries a dual CAR/TCR…
Combinatorial stem cell screening platform for therapy development
Plasticell is a biotechnology company developing cell and gene therapies and enabling drug discovery through its proprietary platform. The technology uses bead-based combinatorial…
AAV gene therapies for rare and neurological diseases
Spur Therapeutics is a clinical-stage biotechnology company developing adeno-associated virus-based gene therapies for serious chronic diseases. Its lead programme is a Phase I/II…
Specialist oncology clinical trial management for biotech and pharma
Karma Oncology is a specialist contract research organisation providing full-service and functional clinical trial management to biotechnology and pharmaceutical companies in…
Bispecific TCR therapies targeting HLA-Class II cancer antigens
Yellowstone Biosciences is a pre-clinical biotechnology company developing bispecific T-cell receptor therapies for oncology. The company targets a novel class of HLA Class II…
Hypothermic gel preservation technology for shipping cells
Atelerix is a biotechnology company supplying hydrogel-based cell and tissue preservation products that eliminate the need for cryogenic cold chain logistics. Its patented…
Automated robotic systems for cell therapy and stem cell manufacture
Sakarta is an instruments and equipment company developing automated robotic solutions for cell therapy and stem cell manufacturing. Working with partners in the UK and Japan, it…
Ex vivo haematopoietic stem cell gene therapies for rare genetic diseases
Orchard Therapeutics is a gene therapy company developing ex vivo haematopoietic stem cell therapies for rare genetic diseases, primarily severe neurometabolic and immunological…
AAV gene therapies for neurodegenerative diseases including FTD and ALS
AviadoBio is a clinical-stage gene therapy company developing AAV-based treatments for neurodegenerative diseases. Its lead programme, AVB-101, is in a Phase 1/2 trial for…